Schwachtgen J L, Janel N, Barek L, Duterque-Coquillaud M, Ghysdael J, Meyer D, Kerbiriou-Nabias D
INSERM U 143, Unité de Recherches sur l'Hémostase et la Thrombose, Hôpital de Bicêtre, France.
Oncogene. 1997 Dec 18;15(25):3091-102. doi: 10.1038/sj.onc.1201502.
von Willebrand factor (vWF) gene expression is restricted to endothelial cells and megakaryocytes. Previous results demonstrated that basal transcription of the human vWF gene is mediated through a promoter located between base pairs -89 and +19 (cap site: +1) which is functional in endothelial and non endothelial cells. Two DNA repeats TTTCCTTT correlating with inverted consensus binding sites for the Ets family of transcription factors are present in the -56/-36 sequence. In order to analyse whether these DNA elements are involved in transcription, human umbilical vein endothelial cells (HUVEC), bovine calf pulmonary endothelial cell line (CPAE), HeLa and COS cells were transfected with constructs containing deletions of the -89/+19 fragment, linked to the chloramphenicol acetyl transferase (CAT) reporter gene. The -60/+19 region exhibits significant promoter activity in HUVEC and CPAE cells only. The -42/+19 fragment is not active. Mutations of the -60/+19 promoter fragment in the 5' (-56/-49) Ets binding site abolish transcription in endothelial cells whereas mutations in the 3' (-43/-36) site does not. The -60/-33 fragment forms three complexes with proteins from HUVEC nuclear extracts in electrophoretic mobility shift assay which are dependent on the presence of the 5' Ets binding site. Binding of recombinant Ets-1 protein to the -60/-33 fragment gives a complex which also depends on the 5' site. The -60/+19 vWF gene core promoter is transactivated in HeLa cells by cotransfecting with Ets-1 or Erg (Ets-related gene) expression plasmids. In contrast to the wild type construct, transcription of the 5' site mutants is not increased by these expressed proteins. The results indicate that the promoter activity of the -60/+19 region of the vWF gene depends on transcription factors of the Ets family of which several members like Ets-1, Ets-2 and Erg are expressed in endothelium. Cotransfection of Ets-1 and Erg expression plasmids is sufficient to induce the -60/+19 vWF promoter activity in HeLa cells.
血管性血友病因子(vWF)基因表达仅限于内皮细胞和巨核细胞。先前的结果表明,人类vWF基因的基础转录是通过位于碱基对-89和+19之间(帽位点:+1)的启动子介导的,该启动子在内皮细胞和非内皮细胞中均有功能。在-56/-36序列中存在两个与转录因子Ets家族的反向共有结合位点相关的DNA重复序列TTTCCTTT。为了分析这些DNA元件是否参与转录,将含有-89/+19片段缺失的构建体与氯霉素乙酰转移酶(CAT)报告基因连接,转染人脐静脉内皮细胞(HUVEC)、牛肺动脉内皮细胞系(CPAE)、HeLa细胞和COS细胞。-60/+19区域仅在HUVEC和CPAE细胞中表现出显著的启动子活性。-42/+19片段无活性。5'(-56/-49)Ets结合位点的-60/+19启动子片段突变会消除内皮细胞中的转录,而3'(-43/-36)位点的突变则不会。在电泳迁移率变动分析中,-60/-33片段与HUVEC核提取物中的蛋白质形成三种复合物,这些复合物依赖于5'Ets结合位点的存在。重组Ets-1蛋白与-60/-33片段的结合产生一种也依赖于5'位点的复合物。通过与Ets-1或Erg(Ets相关基因)表达质粒共转染,-60/+19 vWF基因核心启动子在HeLa细胞中被反式激活。与野生型构建体相比,这些表达蛋白不会增加5'位点突变体的转录。结果表明,vWF基因-60/+19区域的启动子活性取决于Ets家族的转录因子,其中一些成员如Ets-1、Ets-2和Erg在内皮中表达。Ets-1和Erg表达质粒的共转染足以在HeLa细胞中诱导-60/+19 vWF启动子活性。